Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
MAIA Biotechnology Inc. (NYSE : MAIA) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Quote
| Last: | $1.45 |
|---|---|
| Change Percent: | 1.05% |
| Open: | $1.47 |
| Close: | $1.435 |
| High: | $1.56 |
| Low: | $1.44 |
| Volume: | 2,485,981 |
| Last Trade Date Time: | 06/04/2026 01:23:45 pm |
Stock Data
| Market Cap: | $69,250,414 |
|---|---|
| Float: | 32,146,635 |
| Insiders Ownership: | 2.86% |
| Institutions: | 14 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.maiabiotech.com |
| Country: | US |
| City: | Chicago |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : glenn1919
investorshub : Whalatane
investorshub : Stumblebum
investorshub : Whalatane
**MWN-AI FAQ is based on asking OpenAI questions about MAIA Biotechnology Inc. (NYSE: MAIA).
